Medication that is normally used to lower cholesterol could stop the spread of Lyme disease, according to a new study co-authored by Janakiram Seshu, associate professor of biology at The University of Texas at San Antonio ...
May 10, 2016
0
19
People who have peripheral artery disease (PAD) and take cholesterol-lowering drugs called statins have a lower risk of amputation and death than PAD patients who don't take statins. And the higher the dose of statins, the ...
May 6, 2016
0
6
Statins are equally effective at decreasing risk of coronary events in men and women, and yet women are less likely to be prescribed these cholesterol-lowering drugs than men. A study by investigators at Brigham and Women's ...
May 5, 2016
1
2
(HealthDay)—Taking cholesterol-lowering statins right before heart surgery, once touted as a way to prevent common postoperative complications, has no benefit and may even cause harm, a new study suggests.
May 5, 2016
0
56
Long-term use of the cholesterol-lowering drugs known as statins does not appear to decrease a patient's risk of colorectal cancer, suggests a new, large case-control study from Penn Medicine researchers published this week ...
Apr 26, 2016
0
564
The leading cause of death in the elderly, the fastest growing segment of the population, is cardiovascular disease (CVD). Prevention of cardiovascular events in elderly patients presents a therapeutic challenge because this ...
Apr 22, 2016
0
22
(HealthDay)—For patients with hypertriglyceridemia, low-density lipoprotein cholesterol (LDL-C) and triglyceride (TG) reductions depend of the choice and dose of statin, according to research published in the May 1 issue ...
Apr 20, 2016
0
8
The first major clinical trial to include a blinded, placebo-controlled "statin re-challenge" in patients with a history of muscle-related side effects sheds new light on statin-associated muscle symptoms, according to research ...
Apr 4, 2016
0
4
Lowering cholesterol with statins significantly reduced adverse cardiovascular events in people with average cholesterol and blood pressure levels who were considered to be at intermediate risk for heart disease, while the ...
Apr 4, 2016
0
7
In the first major trial of its kind, Cleveland Clinic researchers used a blinded rechallenge with atorvastatin or placebo to objectively confirm the presence of muscle-related symptoms in patients with a history of intolerance ...
Apr 3, 2016
0
27
